TradeStation

Get Cash Back and $0 Commissions
+ The Power of TradeStation

Heart Valve Devices Market 13.3% YoY Growth, US$ 37.5B by 2032

The Market Publicist 31-Oct-2023 3:13 PM

The heart valve devices market is projected to reach a valuation of US$ 11.16 Billion in FY 2022, representing a growth from US$ 9.85 Billion in 2021. Over the previous year, the industry experienced a notable year-on-year increase of 13.3%. Looking ahead, heart valve devices sales are expected to thrive at a compound annual growth rate (CAGR) of 13% from 2022 to 2032, culminating in a value of US$ 37.5 Billion by the conclusion of 2032.

The global heart valve devices market is witnessing remarkable growth, driven by factors such as the rising prevalence of cardiovascular diseases, advancements in medical technology, and an aging population. Heart valve devices play a crucial role in the treatment of heart valve disorders, which can be congenital or acquired. These devices are designed to restore normal blood flow and mitigate the complications associated with dysfunctional heart valves. The market encompasses various types of heart valve devices, including mechanical, bioprosthetic, and transcatheter valves.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4759

Market Opportunity:

The heart valve devices market presents substantial growth opportunities. The increasing incidence of heart valve diseases, primarily attributed to the aging population, unhealthy lifestyles, and genetic predisposition, is a significant driver of market growth. Additionally, the emergence of minimally invasive techniques and transcatheter valve replacement procedures is expanding the markets scope.

The growth in emerging economies offers a promising opportunity for market expansion. The rise in healthcare infrastructure, disposable income, and awareness about advanced medical treatments in these regions contributes to market growth. Moreover, the increasing focus on research and development to enhance the durability and effectiveness of heart valve devices provides manufacturers with a chance to innovate and gain a competitive edge.

Market Challenges:

Despite its promising prospects, the heart valve devices market faces several challenges. One key concern is the high cost of these devices, which can limit their accessibility to a significant portion of the population. The reimbursement policies and insurance coverage for heart valve surgeries and device implantations also pose challenges, as they can vary significantly from one region to another.

Regulatory hurdles and compliance requirements can be cumbersome for manufacturers, often resulting in delayed product approvals and market entry. Furthermore, the complexity of surgical procedures involving heart valve devices demands skilled healthcare professionals, creating a demand-supply gap in some regions. This can hamper the markets growth potential.

Key Players:

  • Edwards Lifesciences Corporation (NYSE:EW)
  • Braile Biomedica
  • St. Jude Medical Inc.
  • Medical Technology Est.
  • Micro Interventional Devices Inc.
  • Boston Scientific Corporation
  • Liva Nova PLC (NASDAQ:LIVN)
  • Cryolife, Inc. (NYSE:AORT)
  • Jena Valve Technology Inc.

Competitive Landscape:

Prominent providers of heart valve devices heavily rely on partnerships, collaborations, acquisitions, and new software launches to maintain their position in the global market. The primary objective of these market leaders is to constantly innovate and ensure a seamless client-customer relationship.

In March 2022, the U.S. Food and Drug Administration (FDA) granted approval to Edwards Lifesciences Corporation for their MITRIS RESILIA valve, a tissue valve replacement specifically designed for the mitral position of the heart.

In January 2022, CryoLife, Inc., a renowned company specializing in cardiac and vascular surgery, announced a rebranding and name change to Artivion, Inc. This change reflects the companys evolution and its commitment to providing innovative technologies to surgeons treating patients with aortic disease. The new name and brand are derived from the words aorta, innovation, and vision.

Key Segments Covered in the Heart Valve Devices Industry Survey

  • Heart Valve Devices by Type
    • Mechanical Heart Valves
      • Aortic Valve
      • Mitral Valve
    • Biological Heart Valve
      • Aortic Valve
      • Mitral Valve
      • Pulmonary Valve
      • Tricuspid Valve
    • Transcatheter Valves
      • Aortic Valve
      • Mitral Valve
      • Pulmonary Valve
  • Heart Valve Devices by End User
    • Heart Valves in Hospitals
    • Heart Valves in Ambulatory Surgical Centers
  • Heart Valve Devices by Region
    • North America Heart Valve Devices Market
    • Latin America Heart Valve Devices Market
    • Europe Heart Valve Devices Market
    • Asia Pacific Heart Valve Devices Market
    • Middle East & Africa Heart Valve Devices Market

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4759

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

Follow Us: LinkedIn | Twitter | YouTube

comtex tracking

COMTEX_442738068/2599/2023-10-31T15:03:44

Market Data Delayed 15 Minutes